KK
Insider
Kevin Koch
President and CEOKevin Koch (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $745K of EWTX (17,058 sh across 2 lots, as filed), executed Aug 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$745K
shares × price, as filed
Last traded
Aug 12
Filed Aug 14
Median ADV $64.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EWTXRecent filings
EWTXSALE
Edgewise Therapeutics, Inc.
View filing →
$745K17,058 sh across 2 lots
Exec Aug 12
Filed Aug 14 · 4:52 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $107K
7,972 sh × $13.39
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $259K
8,636 sh × $30.03
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET